ENB-105 is under development for the treatment of inflammatory bowel disease and immune checkpoint inhibitor colitis (ICI-Colitis). It is being developed based on eSTEM systems biology platform.

BM-219 is under clinical development by Suzhou Biomissile Biopharmaceutical and currently in Phase I for Coronavirus Disease 2019 (COVID-19).

Copper demand is expected to stay red-hot, according to Jorge Cantallopts, an executive director at the Center for Copper and ...

Watsco is a great business with a remarkable historical track record. Click here to read why I have a neutral rating on WSO ...

Detailed price information for Verses Technologies Inc (VERS-NE) from The Globe and Mail including charting and trades.

The success or failure of this transition hinges on the results of ... the target is “3 percent or higher.” “To ensure a phase change in the domestic economy and society, we will aim for ...

Moderna/Merck partnership and its potential in personalised cancer therapies are good opportunities for long-term investors.

Liverpool’s new manager has openly acknowledged that his playing style is not worlds apart from his predecessor, Jurgen Klopp, which has made the transition from one to the other far smoother.

Pharmaceutical and biotech stocks may find it tough to outperform the market in the months ahead. That is the view of UBS ...

The World Bank in its latest report has highly appreciated the policies and the high tech moves of the Vietnam Government and ...

The S&P 500's returns are measured using time-weighted returns (TWR), which don't account for cash flows like withdrawals. If you're retired and withdrawing funds, comparing your portfolio to the S&P ...

The war between Russia and Ukraine has now entered its 1044th day since starting on February 24, 2022. In this relatively short time, drones have become a bona fide tour de force on the battlefield.